| Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
| Tel: |
15076683720 |
| Email: |
klq@cw-bio.com |
| Products Intro: |
Product Name:SARS-CoV-2-IN-38
CAS:2882823-27-8
Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
| Company Name: |
Shanghai Yifei Biotechnology Co. , Ltd.
|
| Tel: |
021-65675885 18964387627 |
| Email: |
customer_service@efebio.com |
| Products Intro: |
Product Name:SARS-CoV-2-IN-38
CAS:2882823-27-8
Purity:99.00% Package:1mg;5mg;10mg
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:SARS-CoV-2-IN-38
CAS:2882823-27-8
Purity:99.39% Package:1mg/RMB 1980;5mg/RMB 4920;10mg/RMB 7130
|
SARS-CoV-2-IN-38 manufacturers
- SARS-CoV-2-IN-38
-
- $293.00 / 1mg
-
2025-09-18
- CAS:2882823-27-8
- Min. Order:
- Purity: 99.37%
- Supply Ability: 10g
|
| | SARS-CoV-2-IN-38 Basic information |
| | SARS-CoV-2-IN-38 Chemical Properties |
| | SARS-CoV-2-IN-38 Usage And Synthesis |
| Uses | SARS-CoV-2-IN-38 (compound 24) is a SARS-CoV-2 inhibitor with good oral bioavailability in mice (F%=39.75%)[1]. | | References | [1] Li R, et al. Synthesis, cytotoxicity, and pharmacokinetic evaluations of niclosamide analogs for anti-SARS-CoV-2. Eur J Med Chem. 2023 May 5;253:115320. DOI:10.1016/j.ejmech.2023.115320 |
| | SARS-CoV-2-IN-38 Preparation Products And Raw materials |
|